Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm

International Immunopharmacology(2021)10.1016/j.intimp.2021.107571Source: DataRank Database

The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm is a research paper published in International Immunopharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 61 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access61 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.13)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jeffrey K. Actor ORCID,Marian L. Kruzel ORCID,Michał Zimecki ORCID

Live enrichment

PubMed:33765614 PMC:PMC7953442 OpenAlex:https://openalex.org/W3136220751

National Institutes of Health

Grant: R42-AI051050-05

NIAID NIH HHS

Grant: R42 AI117990

NIAID NIH HHS

Grant: R42 AI051050

National Institutes of Health

Grant: 2R42AI051050-04

Lactoferrin as an Adjuvant for Cellular Immunity

FWCI

6.13

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.intimp.2021.107571

publisherhttps://doi.org/10.1016/j.intimp.2021.107571

publisherhttps://api.elsevier.com/content/article/PII:S1567576921002071?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1567576921002071?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33765614

Fields of Study

Infant Nutrition and HealthCOVID-19 Impact on ReproductionCOVID-19 Clinical Research Studies0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Gastrointestinal MicrobiomeCytokine Release SyndromeCOVID-19AnimalsHumansLactoferrinLungRespiratory Distress SyndromeCytokines

Keywords

Cytokine stormLactoferrinCytokineImmunologyImmune systemCoronavirusMedicineInflammationTumor necrosis factor alphaOxidative stressBiologyCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)ImmunopathologyCovid-19Sars-cov-2Respiratory Distress SyndromeReviewGastrointestinal MicrobiomeAnimalsCytokinesHumansCytokine Release SyndromeLung

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm

FAIR Checklist

Authors (3)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)